ANAPHYLATOXINS IN DILATED CARDIOMYOPATHY

被引:5
|
作者
SAMSONOV, M [1 ]
NASSONOV, E [1 ]
MASENKO, V [1 ]
NAUMOV, V [1 ]
MAREEV, V [1 ]
BELENKOV, Y [1 ]
机构
[1] CARDIOL RES CTR,INST CARDIOL,CLIN IMMUNOL LAB,MOSCOW,RUSSIA
关键词
ANAPHYLATOXINS; DILATED CARDIOMYOPATHY; THROMBOEMBOLIC COMPLICATIONS;
D O I
10.1111/j.1365-2796.1993.tb00722.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP). Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with hypertrophic cardiomyopathy (HCMP) and 11 healthy volunteers. Results. The mean C3a concentration was significantly higher in DCMP patients (5 72 +/- 55 ng ml-1) compared with hypertrophic cardiomyopathy (344 +/- 30 ng ml-1) and with healthy controls (294 +/- 43 ng ml-1) (P<0.001). There were no significant correlations for C5a concentrations in this group. Mean C3a concentration in DCMP patients with thromboembolic complications (736 +/- 95 ng ml-1) was also significantly higher compared with DCMP patients without these complications (344 +/- 14 ng ml-1) (P<0.001). Conclusions. We conclude that anaphylatoxins may play a role in the pathogenesis of thromboembolic complications.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [41] Familial inflammatory dilated cardiomyopathy
    Portig, Irene
    Wilke, Andreas
    Freyland, Matthias
    Wolf, Markus-Joachim
    Richter, Anette
    Ruppert, Volker
    Pankuweit, Sabine
    Maisch, Bernhard
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (08) : 816 - 825
  • [42] Diagnostic biomarkers of dilated cardiomyopathy
    Moeinafshar, Aysan
    Yazdanpanah, Niloufar
    Rezaei, Nima
    IMMUNOBIOLOGY, 2021, 226 (06)
  • [43] The role of apoptosis in dilated cardiomyopathy
    Schaper, J
    Lorenz-Meyer, S
    Suzuki, K
    HERZ, 1999, 24 (03) : 219 - 224
  • [44] Dolichocarotids and dilated cardiomyopathy: Is there a relationship?
    Ciccone, Marco Matteo
    Scicchitano, Pietro
    Palumbo, Vincenzo
    Cortese, Francesca
    Valecce, Rosanna
    Dentamaro, Ilaria
    Dachille, Annamaria
    Carbonara, Rosa
    Federico, Francesco
    Iacoviello, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 123 - 125
  • [45] Genetics of familial dilated cardiomyopathy
    Menon, Shaji C.
    Olson, Timothy M.
    Michels, Virginia V.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2008, 25 (01) : 57 - 67
  • [46] Echocardiographic Advances in Dilated Cardiomyopathy
    Faggiano, Andrea
    Avallone, Carlo
    Gentile, Domitilla
    Provenzale, Giovanni
    Toriello, Filippo
    Merlo, Marco
    Sinagra, Gianfranco
    Carugo, Stefano
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [47] Evolving concepts in dilated cardiomyopathy
    Merlo, Marco
    Cannata, Antonio
    Gobbo, Marco
    Stolfo, Davide
    Elliott, Perry M.
    Sinagra, Gianfranco
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (02) : 228 - 239
  • [48] Genetic aspects of dilated cardiomyopathy
    OrtizLopez, R
    Schultz, KR
    Towbin, JA
    PROGRESS IN PEDIATRIC CARDIOLOGY, 1996, 6 (01) : 71 - 82
  • [49] Genetic causes of dilated cardiomyopathy
    Mestroni, Luisa
    Brun, Francesca
    Spezzacatene, Anita
    Sinagra, Gianfranco
    Taylor, Matthew R. G.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2014, 37 (1-2) : 13 - 18
  • [50] Immunoadsorption in patients with dilated cardiomyopathy
    Herda, Lars R.
    Felix, Stephan B.
    Staudt, Alexander
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (05) : 126 - 128